{"id":329317,"date":"2026-10-28T10:14:50","date_gmt":"2026-10-28T04:44:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=329317"},"modified":"2026-10-28T10:14:50","modified_gmt":"2026-10-28T04:44:50","slug":"midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Midcap Latest Quarter Revenue Growth 10-20 Per Cent Stocks to Watch for Future Multibagger Potential: Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Max Healthcare Rs 845. Godrej Consumer Rs 828.80. Phoenix Mills Rs 1,905. Mphasis Rs 2,618.40. Market caps from Rs 49,108 crore to Rs 86,261 crore. Data as of 27 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis are the 4 picks in this latest quarter revenue growth 10-20 per cent stocks watchlist, with market caps between Rs 49,108 crore and Rs 86,261 crore. Max Healthcare stands out for the largest market cap at Rs 86,261 crore, while Godrej Consumer offers 7.90% revenue growth in FY26. PE ratios run from 25.71 to 59.20, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.<\/p>\n<\/p><\/div>\n<p>Latest quarter revenue growth 10-20 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis meet that test, with market caps from Rs 49,108 crore to Rs 86,261 crore and Max Healthcare offering the largest market cap at Rs 86,261 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and latest quarter revenue growth between 10 and 20 per cent over the same quarter a year earlier, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and latest quarter revenue growth between 10 and 20 per cent over the same quarter a year earlier, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening latest quarter revenue growth 10-20 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=latest-quarter-revenue-growth-per-cent-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#What_Are_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Latest Quarter Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?\">What Are Latest Quarter Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Latest Quarter Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE\">Latest Quarter Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Max_Healthcare_2426_Profit_CAGR_Since_FY22\" title=\"Max Healthcare: 24.26% Profit CAGR Since FY22\">Max Healthcare: 24.26% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Godrej_Consumer_Profit_Compounding_at_108_a_Year\" title=\"Godrej Consumer: Profit Compounding at 1.08% a Year\">Godrej Consumer: Profit Compounding at 1.08% a Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Phoenix_Mills_5828_Profit_CAGR_Since_FY22\" title=\"Phoenix Mills: 58.28% Profit CAGR Since FY22\">Phoenix Mills: 58.28% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Mphasis_Profit_Compounding_at_681_a_Year\" title=\"Mphasis: Profit Compounding at 6.81% a Year\">Mphasis: Profit Compounding at 6.81% a Year<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Latest Quarter Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins\">Latest Quarter Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Max_Healthcare_Godrej_Consumer_Phoenix_Mills_and_Mphasis\" title=\"Institutional Holding in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis\">Institutional Holding in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks\" title=\"Risks to Weigh in Latest Quarter Revenue Growth 10-20 Per Cent Stocks\">Risks to Weigh in Latest Quarter Revenue Growth 10-20 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks\" title=\"How to Choose Between Latest Quarter Revenue Growth 10-20 Per Cent Stocks\">How to Choose Between Latest Quarter Revenue Growth 10-20 Per Cent Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_to_Watch\" title=\"Frequently Asked Questions on Latest Quarter Revenue Growth 10-20 Per Cent Stocks to Watch\">Frequently Asked Questions on Latest Quarter Revenue Growth 10-20 Per Cent Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Which_are_the_best_latest_quarter_revenue_growth_10-20_per_cent_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best latest quarter revenue growth 10-20 per cent stocks to watch for multibagger potential?\">Which are the best latest quarter revenue growth 10-20 per cent stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Is_Mphasis_a_good_stock_for_long-term_investors\" title=\"Is Mphasis a good stock for long-term investors?\">Is Mphasis a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Can_Phoenix_Mills_become_a_multibagger_from_here\" title=\"Can Phoenix Mills become a multibagger from here?\">Can Phoenix Mills become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Max_Healthcare_Godrej_Consumer_Phoenix_Mills_and_Mphasis\" title=\"What is the market cap of Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?\">What is the market cap of Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_latest_quarter_revenue_growth_10-20_per_cent_stocks\" title=\"What are the risks of investing in latest quarter revenue growth 10-20 per cent stocks?\">What are the risks of investing in latest quarter revenue growth 10-20 per cent stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#Why_is_Mphasis_trading_at_a_PE_of_2571\" title=\"Why is Mphasis trading at a PE of 25.71?\">Why is Mphasis trading at a PE of 25.71?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Max_Healthcare_Godrej_Consumer_Phoenix_Mills_and_Mphasis\" title=\"How much do institutions hold in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?\">How much do institutions hold in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Latest Quarter Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Latest quarter revenue growth 10-20 per cent stocks are shares of mid sized companies whose sales in the latest quarter grew 10 to 20 per cent over the same quarter last year, a sign that demand for their products is holding up well. The four here cover hospitals, household products, malls and IT services.<\/p>\n<p>Quarterly sales growth in this range, backed by rising full-year profit, shows demand that is growing without any strain on the business. Within latest quarter revenue growth 10-20 per cent stocks, the four companies show rising profit. For latest quarter revenue growth 10-20 per cent stocks, both FY26 and the latest quarter showed growth. Whichever way you read latest quarter revenue growth 10-20 per cent stocks, the common thread is rising profit backed by complete financial data. With latest quarter revenue growth 10-20 per cent stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for latest quarter revenue growth 10-20 per cent stocks are complete. Read each company&#8217;s latest results and exchange filings before acting on latest quarter revenue growth 10-20 per cent stocks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Latest Quarter Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 27 October 2026. Mphasis combines the lowest PE of the group, 25.71, with the highest return on equity, 17.34%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/maxhealth\/max-healthcare-institute-ltd-share-price-today\">Max Healthcare Institute<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">845<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">86,261<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">59.20<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.32<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">815.00 to 1,221.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/godrejcp\/godrej-consumer-products-ltd-share-price-today\">Godrej Consumer Products<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">828.80<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">84,348<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.08<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.40<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.35<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">828.80 to 1,273.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/phoenixltd\/the-phoenix-mills-ltd-share-price-today\">Phoenix Mills<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,905<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">68,990<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.32<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.56<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.14%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.48<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,465.60 to 2,169.80<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/mphasis\/mphasis-ltd-share-price-today\">Mphasis<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,618.40<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">49,108<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.71<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.49<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.34%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.24<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,013.00 to 2,975.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Max_Healthcare_2426_Profit_CAGR_Since_FY22\"><\/span><strong>Max Healthcare: 24.26% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Max Healthcare Institute runs a network of multi-speciality hospitals in Delhi NCR, Mumbai and other cities. It reported FY26 revenue of Rs 8,536.07 crore, up 18.82% year on year, and net profit of Rs 1,442.41 crore, up 34.07%. Net profit has compounded at 24.26% a year since FY22, while revenue has grown 20.42% a year. Operating margin was 28.15% in FY26. The debt-to-equity ratio is 0.32.<\/p>\n<p>In the June 2026 quarter, revenue rose 16.60% to Rs 2,406.69 crore and net profit grew 4.87% to Rs 322.96 crore. The share price has gained 149.91% over five years. Domestic institutions raised their holding from 17.42% in June 2025 to 29.96% in June 2026. The stock trades at a PE of 59.20 against an industry PE of 60.75, below the sector average, with a return on equity of 13.42%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Godrej_Consumer_Profit_Compounding_at_108_a_Year\"><\/span><strong>Godrej Consumer: Profit Compounding at 1.08% a Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Godrej Consumer Products sells household insecticides, soaps, hair colour and personal care brands in India, Africa and Asia. It reported FY26 revenue of Rs 15,444.07 crore, up 7.90% year on year, and net profit of Rs 1,861.47 crore, up 0.50%. Revenue has compounded at 5.71% a year since FY22. Operating margin was 19.45% in FY26. The debt-to-equity ratio is 0.35.<\/p>\n<p>The stock trades at a PE of 44.08 against an industry PE of 34.40, with a return on equity of 14.71%. The dividend yield is 2.43%. In the June 2026 quarter, revenue rose 14.17% to Rs 4,277.35 crore and net profit grew 11.51% to Rs 504.52 crore. Domestic institutions raised their holding from 12.40% in June 2025 to 19.59% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Phoenix_Mills_5828_Profit_CAGR_Since_FY22\"><\/span><strong>Phoenix Mills: 58.28% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Phoenix Mills owns and runs large retail malls across India under the Phoenix Marketcity and Palladium brands, along with offices, hotels and residences. It reported FY26 revenue of Rs 4,593.55 crore, up 15.87% year on year, and net profit of Rs 1,556.61 crore, up 19.60%. Net profit has compounded at 58.28% a year since FY22, while revenue has grown 31.04% a year. Operating margin was 62.83% in FY26. The debt-to-equity ratio is 0.48.<\/p>\n<p>In the June 2026 quarter, revenue rose 13.27% to Rs 1,115.15 crore and net profit grew 23.02% to Rs 393.55 crore. The share price has gained 303.49% over five years and 11.92% over the past year. Domestic institutions raised their holding from 15.47% in September 2025 to 17.31% in September 2026. The stock trades at a PE of 42.32 against an industry PE of 31.56.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mphasis_Profit_Compounding_at_681_a_Year\"><\/span><strong>Mphasis: Profit Compounding at 6.81% a Year<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mphasis provides IT, cloud and application services to banking, insurance and technology clients. It reported FY26 revenue of Rs 16,205.54 crore, up 11.88% year on year, and net profit of Rs 1,862.60 crore, up 9.43%. Net profit has compounded at 6.81% a year since FY22, while revenue has grown 7.53% a year. Operating margin was 20.58% in FY26. The debt-to-equity ratio is 0.24.<\/p>\n<p>The stock trades at a PE of 25.71 against an industry PE of 18.49, with a return on equity of 17.34%. The dividend yield is 2.41%. In the June 2026 quarter, revenue rose 17.14% to Rs 4,466.91 crore and net profit grew 10.82% to Rs 489.51 crore. Domestic institutions raised their holding from 37.07% in September 2025 to 45.85% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Latest Quarter Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these latest quarter revenue growth 10-20 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Max Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8,536.07<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,442.41<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">18.82%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.26%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.00%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Godrej Consumer<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15,444.07<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,861.47<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.90%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1.08%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Phoenix Mills<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,593.55<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,556.61<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.87%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.04%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">58.28%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">63.42%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Mphasis<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16,205.54<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,862.60<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.81%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.04%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these latest quarter revenue growth 10-20 per cent stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Max_Healthcare_Godrej_Consumer_Phoenix_Mills_and_Mphasis\"><\/span><strong>Institutional Holding in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these latest quarter revenue growth 10-20 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Max Healthcare has the deepest institutional backing, with FII and DII together holding 71.74% as of June 2026. Domestic institutions increased their holding over the past year in Max Healthcare (from 17.42% to 29.96%), Godrej Consumer (from 12.40% to 19.59%), Phoenix Mills (from 15.47% to 17.31%) and Mphasis (from 37.07% to 45.85%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Max Healthcare<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.71%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">41.78%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">29.96%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Godrej Consumer<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">53.05%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.33%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.59%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.03%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Phoenix Mills<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">47.24%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Mphasis<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">30.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.39%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">45.85%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4.23%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks\"><\/span><strong>Risks to Weigh in Latest Quarter Revenue Growth 10-20 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with latest quarter revenue growth 10-20 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> Mphasis trades at a PE of 25.71 against an industry PE of 18.49, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks\"><\/span><strong>How to Choose Between Latest Quarter Revenue Growth 10-20 Per Cent Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from latest quarter revenue growth 10-20 per cent stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (18.49 to 60.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among latest quarter revenue growth 10-20 per cent stocks, Max Healthcare stands out for the largest market cap at Rs 86,261 crore, Godrej Consumer for 7.90% revenue growth in FY26, Phoenix Mills for the fastest profit growth, 58.28% a year since FY22 and Mphasis for the highest return on equity at 17.34%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing latest quarter revenue growth 10-20 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Latest_Quarter_Revenue_Growth_10-20_Per_Cent_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Latest Quarter Revenue Growth 10-20 Per Cent Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_latest_quarter_revenue_growth_10-20_per_cent_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best latest quarter revenue growth 10-20 per cent stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis are the 4 names this list highlights, with market caps of Rs 86,261 crore, Rs 84,348 crore, Rs 68,990 crore and Rs 49,108 crore respectively. Max Healthcare is notable for the largest market cap at Rs 86,261 crore. Godrej Consumer stands out for 7.90% revenue growth in FY26. Phoenix Mills offers the fastest profit growth, 58.28% a year since FY22. Mphasis brings the highest return on equity at 17.34%. These are watchlist names for latest quarter revenue growth 10-20 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Mphasis_a_good_stock_for_long-term_investors\"><\/span><strong>Is Mphasis a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mphasis has a return on equity of 17.34%, a PE of 25.71 against an industry PE of 18.49 and a market cap of Rs 49,108 crore. Net profit has compounded at 6.81% a year since FY22, and FY26 revenue rose 11.88% while June 2026 quarter net profit grew 10.82%. Long-term returns in latest quarter revenue growth 10-20 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Phoenix_Mills_become_a_multibagger_from_here\"><\/span><strong>Can Phoenix Mills become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Phoenix Mills has already gained 303.49% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in latest quarter revenue growth 10-20 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 58.28% a year since FY22, and FY26 revenue rose 15.87%. At a PE of 42.32 against an industry PE of 31.56, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Max_Healthcare_Godrej_Consumer_Phoenix_Mills_and_Mphasis\"><\/span><strong>What is the market cap of Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 27 October 2026, Max Healthcare has a market cap of Rs 86,261 crore, Godrej Consumer has a market cap of Rs 84,348 crore, Phoenix Mills has a market cap of Rs 68,990 crore and Mphasis has a market cap of Rs 49,108 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on latest quarter revenue growth 10-20 per cent stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_latest_quarter_revenue_growth_10-20_per_cent_stocks\"><\/span><strong>What are the risks of investing in latest quarter revenue growth 10-20 per cent stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Mphasis trades at a PE of 25.71 against an industry PE of 18.49, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Mphasis_trading_at_a_PE_of_2571\"><\/span><strong>Why is Mphasis trading at a PE of 25.71?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mphasis&#8217; PE of 25.71 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 17.34% and latest-quarter profit growth of 10.82%, which also means the stock is more sensitive if growth slows. Investors in latest quarter revenue growth 10-20 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Max_Healthcare_Godrej_Consumer_Phoenix_Mills_and_Mphasis\"><\/span><strong>How much do institutions hold in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 71.74% of Max Healthcare (41.78% and 29.96%), 31.92% of Godrej Consumer (12.33% and 19.59%), 48.93% of Phoenix Mills (31.62% and 17.31%) and 65.24% of Mphasis (19.39% and 45.85%). Rising institutional holding is a useful signal in latest quarter revenue growth 10-20 per cent stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best latest quarter revenue growth 10-20 per cent stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis are the 4 names this list highlights, with market caps of Rs 86,261 crore, Rs 84,348 crore, Rs 68,990 crore and Rs 49,108 crore respectively. Max Healthcare is notable for the largest market cap at Rs 86,261 crore. Godrej Consumer stands out for 7.90% revenue growth in FY26. Phoenix Mills offers the fastest profit growth, 58.28% a year since FY22. Mphasis brings the highest return on equity at 17.34%. These are watchlist names for latest quarter revenue growth 10-20 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Mphasis a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mphasis has a return on equity of 17.34%, a PE of 25.71 against an industry PE of 18.49 and a market cap of Rs 49,108 crore. Net profit has compounded at 6.81% a year since FY22, and FY26 revenue rose 11.88% while June 2026 quarter net profit grew 10.82%. Long-term returns in latest quarter revenue growth 10-20 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Phoenix Mills become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Phoenix Mills has already gained 303.49% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in latest quarter revenue growth 10-20 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 58.28% a year since FY22, and FY26 revenue rose 15.87%. At a PE of 42.32 against an industry PE of 31.56, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 27 October 2026, Max Healthcare has a market cap of Rs 86,261 crore, Godrej Consumer has a market cap of Rs 84,348 crore, Phoenix Mills has a market cap of Rs 68,990 crore and Mphasis has a market cap of Rs 49,108 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on latest quarter revenue growth 10-20 per cent stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in latest quarter revenue growth 10-20 per cent stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Mphasis trades at a PE of 25.71 against an industry PE of 18.49, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Mphasis trading at a PE of 25.71?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Mphasis' PE of 25.71 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 17.34% and latest-quarter profit growth of 10.82%, which also means the stock is more sensitive if growth slows. Investors in latest quarter revenue growth 10-20 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 71.74% of Max Healthcare (41.78% and 29.96%), 31.92% of Godrej Consumer (12.33% and 19.59%), 48.93% of Phoenix Mills (31.62% and 17.31%) and 65.24% of Mphasis (19.39% and 45.85%). Rising institutional holding is a useful signal in latest quarter revenue growth 10-20 per cent stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 midcap latest quarter revenue growth 10-20 per cent stocks compared on market cap, PE, ROE, growth and institutional holding: Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis.<\/p>\n","protected":false},"author":33,"featured_media":329316,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[16934,16933],"class_list":["post-329317","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-latest-quarter-revenue-growth-10-20-per-cent-sector","tag-latest-quarter-revenue-growth-10-20-per-cent-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["329316"],"rank_math_title":["Latest Quarter Revenue Growth 10-20 Per Cent Stocks to Watch"],"rank_math_description":["Latest quarter revenue growth 10-20 per cent stocks for multibagger potential: Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis. PE, ROE and growth compared."],"rank_math_focus_keyword":["latest quarter revenue growth 10-20 per cent stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-midcap-latest-quarter-revenue-growth-10-20-per-cent-stocks-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=329317"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329317\/revisions"}],"predecessor-version":[{"id":329318,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/329317\/revisions\/329318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/329316"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=329317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=329317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=329317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}